Legal representation in Switzerland

ACOLIN takes care of approval for your investment funds in Switzerland and acts as a legal representative here.

Our aim is to support the development and successful operation of your fund business in Switzerland, enabling you to obtain approval/registration of your investment fund by the Swiss Financial Market Supervisory Authority FINMA within an appropriate period of time and to achieve public distribution of your product on the Swiss market.

Following approval/registration of your investment fund, we ensure approval is maintained through continuous and timely fulfilment of all legal and regulatory duties in Switzerland. This includes the creation of notifications and publications for investors and reporting to the authorities, as well as issuing fund documentation. We also help you with the distribution of your investment funds by drawing up and concluding distribution agreements, as well as constantly supervising distributors.

Legal advice/ feasibility studies	ACOLIN reviews foreign fund prospectuses with regard to their conformity to Swiss laws and regulations. It also provides general legal advice as well as feasibility studies.
Registration in Switzerland	As a legal representative, authorised and supervised by the FINMA, ACOLIN undertakes preparation and registration of the funds in Switzerland.
Mandatory publications	ACOLIN arranges the prescribed, regular publication of fund prices and other mandatory publications in the fund organs.
Mandatory notifications	ACOLIN issues all legally requested notifications and forwards annual and semi-annual reports of the funds to FINMA and others in due time.
Legally compliant advertise- ment and investors’ information	ACOLIN ensures that advertisements and investors’ information fully comply with the investors’ statutory and self-regulatory specifications.
Information and supervision of distributors	ACOLIN instructs distributors and supervises their compliance with the statutory and self-regulatory specifications applicable to them.